Cochrane Evidence Synthesis and Methods ►

Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus

To systematically evaluate the beneficial and harmful effects of adding protease inhibitors to the current standard treatment of chronic hepatitis C with pegylated interferon and ribavirin.

This is a protocol.

Health topics:

Gastroenterology & hepatology > Liver disorders > Hepatitis C

Infectious disease > Liver infections > Hepatitis C

Published:

18 June 2013

Authors:

Yaseen AlSabbagh M, Davitkov P, Falck-Ytter Y

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Yaseen AlSabbagh M, Davitkov P, Falck-Ytter Y. Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010587. DOI: 10.1002/14651858.CD010587